NCT00010166View on ClinicalTrials.gov

Gemcitabine and Radiation Therapy in Treating Patients With Cancer of the Pancreas

PHASE2CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

December 1, 2000

Primary Completion Date

October 3, 2003

Study Completion Date

October 3, 2003

Conditions
Pancreatic Cancer
Interventions
DRUG

gemcitabine hydrochloride

PROCEDURE

adjuvant therapy

RADIATION

radiation therapy

Trial Locations (1)

27157-1082

Comprehensive Cancer Center at Wake Forest University, Winston-Salem

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Wake Forest University Health Sciences

OTHER

NCT00010166 - Gemcitabine and Radiation Therapy in Treating Patients With Cancer of the Pancreas | Biotech Hunter | Biotech Hunter